The nocebo effect during oral challenge in subjects with adverse drug reactions

European Annals of Allergy and Clinical Immunology

Volumn 40, Issue 4, 2008, Pages 138-141

  Lombardi, C ^a   Gargioni, S ^a   Canonica, G W ^b   Passalacqua, G ^b  

^a Sant'Orsola FBF Hospital   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Adverse drug reaction; Drug challenge; Nocebo effect

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ABDOMINAL PAIN; ADULT; ADVERSE DRUG REACTION; AGED; ANGIONEUROTIC EDEMA; ANXIETY; ARTICLE; BLINDNESS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; MALAISE; MALE; PLACEBO EFFECT; PRURITUS; QUESTIONNAIRE; URTICARIA;

ABDOMINAL PAIN; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ALLERGENS; ANGIOEDEMA; ANXIETY; DEPRESSION; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNIZATION; MALE; MIDDLE AGED; PLACEBO EFFECT; PRURITUS; QUESTIONNAIRES; RESPIRATORY SOUNDS; SEX FACTORS; TALC; URTICARIA;

EID: 59749102445     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Beecher HK. The powerful placebo. JAMA 1995; 159: 1602-06.
2. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994; 271. 1609-14.
3. Vickers AJ, de Craen AJ. Why use placebos in clinical trials? A narrative review of the methodological literature. J Clin Epidemiol 2000; 53: 157-61.
4. Kleijnen J, de Craen AJ, van Everdingen J, Krol L. Placebo effect in double blind clinical trials: a review of it interaction with medications. Lancet 1994; 344: 1347-9.
5. Keeley R. When are medication side effects due to the nocebo phenomenon? JAMA. 2002 May 15;287(19):2503; author reply 2503-4.
6. Bernstein IL, Gruchalla RS, Lerr ER, Nicklas RA, Dykewicz MS edts. Disease Management of Drug Hypersensitivity: A Practice Parameter. Ann Allergy Asthma Immunol 1999; 83: 667-71.
7. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, Brockow K, Pichler WJ, Demoly P; European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-63.
8. Passalacqua G, Milanese M, Mincarini M. et al. Single dose oral tolerance test with alternative compounds for the management of adverse reactions to drugs. Int Arch Allergy Immunol 2002; 129: 242-7.
9. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 52: 69-77.
10. Ernst E, Resch KL: Concept of true and perceived placebo effects. BJM 1995; 311: 551-53.
11. Barsky AJ, Saintfort R, Rogers MP, Bours JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002; 287: 622-7.
12. Liccardi G, Senna G, Russo M, Bonadonna P, Crivellaro M, Dama A, D'Amato M, D'Amato G, Canonica GW, Passalacqua G. Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions.J Investig Allergol Clin Immunol. 2004; 14:104-7.
13. Strohle A. Increased response to a putative panicogenic nocebo administration in female patients with panic disorder. J Psychiatr Res 2000; 34: 439-42.